Adcock's Largest Stakeholder Declines To Help Sell Firm To CFR
This article was originally published in PharmAsia News
Executive Summary
South Africa's Public Investment Corp., has decided not to participate in a proposed $1.2 billion sale of Adcock Ingram Holdings to CFR Pharmaceuticals of Chile, possibly dooming the merger.